Wells Fargo & Company Phasebio Pharmaceuticals Inc C Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
N/A
14 Added 0.77%
1,821 $0
Q2 2022

Aug 12, 2022
BUY
N/A
21 Added 1.18%
1,807 $1,000
Q1 2022

May 16, 2022
BUY
N/A
1 Added 0.06%
1,786 $2,000
Q4 2021

Feb 14, 2022
SELL
N/A
-8,812 Reduced 83.16%
1,785 $5,000
Q3 2021

Nov 15, 2021
BUY
N/A
8,793 Added 487.42%
10,597 $33,000
Q2 2021

Aug 16, 2021
SELL
N/A
-4,513 Reduced 71.44%
1,804 $7,000
Q1 2021

May 13, 2021
SELL
N/A
-18,475 Reduced 74.52%
6,317 $21,000
Q4 2020

Feb 09, 2021
BUY
N/A
3,747 Added 17.8%
24,792 $83,000
Q3 2020

Nov 05, 2020
SELL
N/A
-3,937 Reduced 15.76%
21,045 $74,000
Q2 2020

Aug 13, 2020
BUY
N/A
8,150 Added 48.42%
24,982 $114,000
Q1 2020

May 14, 2020
BUY
N/A
16,832 New
16,832 $55,000

About PHASEBIO PHARMACEUTICALS INC C

PHASQ Quotes by TradingView
  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email